Get started
222

IL DONG PHARM

No trades
See on Supercharts
Overview
Financials News Discussions Technicals

249420 chart


Full chart

Key stats


Market capitalization
‪387.86 B‬KRW
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1,810KRW
Net income (FY)
‪−78.93 B‬KRW
Revenue (FY)
‪600.76 B‬KRW
Shares float
‪15.71 M‬
Beta (1Y)
0.83

About IL DONG PHARM


Sector
Health Technology
CEO
Woong-Sub Yoon
Headquarters
Seoul
Website
ildong.com
Employees (FY)
‪1.01 K‬
Founded
2016
ISIN
KR7249420001
FIGI
BBG00CF4FTT7
Ildong Pharmaceutical Co., Ltd. engages in the manufacture and sale of medicines, ingredients for medicines, health supplements and special nutritional products. Its products include vitamins, antibiotics, gastric ulcer medicine, peptic ulcerative agents, and diet pills. The company was founded on August 1, 2016 and is headquartered in Seoul, South Korea.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

News



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Frequently Asked Questions


The current price of 249420 is 13,950 KRW — it hasn't changed in the past 24 hours. Watch IL DONG PHARM stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange IL DONG PHARM stocks are traded under the ticker 249420.
249420 stock has fallen by −0.85% compared to the previous week, the month change is a −23.98% fall, over the last year IL DONG PHARM has showed a −30.60% decrease.
249420 reached its all-time high on Apr 6, 2022 with the price of 79,500 KRW, and its all-time low was 9,280 KRW and was reached on Mar 19, 2020. View more price dynamics on 249420 chart.
See other stocks reaching their highest and lowest prices.
249420 stock is 3.97% volatile and has beta coefficient of 0.83. Track IL DONG PHARM stock price on the chart and check out the list of the most volatile stocks — is IL DONG PHARM there?
Yes, you can track IL DONG PHARM financials in yearly and quarterly reports right on TradingView.
249420 net income for the last quarter is ‪−3.24 B‬ KRW, while the quarter before that showed ‪−833.32 M‬ KRW of net income which accounts for −288.71% change. Track more IL DONG PHARM financial stats to get the full picture.
As of Sep 20, 2024, the company has ‪1.01 K‬ employees. See our rating of the largest employees — is IL DONG PHARM on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IL DONG PHARM EBITDA is ‪7.20 B‬ KRW, and current EBITDA margin is −4.18%. See more stats in IL DONG PHARM financial statements.
Like other stocks, 249420 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IL DONG PHARM stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So IL DONG PHARM technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating IL DONG PHARM stock shows the sell signal. See more of IL DONG PHARM technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.